Clinical Trials Logo

Clinical Trial Summary

Although the acute and chronic postoperative pain of surgical patients has gradually been paid attention to, it has not yet been better resolved.and, the incidence of anxiety and depression in cancer patients is constantly increasing,The new analgesic anesthetic esketamine hydrochloride was launched in China last year,however, in the domestic and foreign literature, there are still few reports of esketamine hydrochloride in postoperative analgesia, and most of them are retrospective and small samples.This study aims to investigate whether esketamine has advantages over traditional opioids in terms of postoperative analgesia, anxiety and depression in cancer patients.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04613869
Study type Interventional
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact
Status Active, not recruiting
Phase N/A
Start date August 15, 2020
Completion date October 15, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT02792270 - Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT N/A